DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Gadopentetic acid

Gadopentetic acid

  • The Study Programme for the Quality Management of Essential Medicines - Good Manufacturing Practical (GMP) and Inspection

    The Study Programme for the Quality Management of Essential Medicines - Good Manufacturing Practical (GMP) and Inspection

  • Drug-Induced Anaphylaxis in China: a 10 Year Retrospective Analysis of The

    Drug-Induced Anaphylaxis in China: a 10 Year Retrospective Analysis of The

  • National Code Item Name 1

    National Code Item Name 1

  • Chemical Modifications of Porous Shape Memory Polymers For

    Chemical Modifications of Porous Shape Memory Polymers For

  • Advisory Committee Briefing Document Medical Imaging Drugs Advisory Committee (MIDAC) September 8, 2017

    Advisory Committee Briefing Document Medical Imaging Drugs Advisory Committee (MIDAC) September 8, 2017

  • Optimisation of a New Class of Peptide-Based MRI Contrast Agent

    Optimisation of a New Class of Peptide-Based MRI Contrast Agent

  • Art. 31 Gadolinium

    Art. 31 Gadolinium

  • Safety of Gadolinium-Based Contrast Agents in Patients with Stage 4 and 5 Chronic Kidney Disease: a Radiologist's Perspective

    Safety of Gadolinium-Based Contrast Agents in Patients with Stage 4 and 5 Chronic Kidney Disease: a Radiologist's Perspective

  • How Does Contrast Media Affect Cardiac Markers And

    How Does Contrast Media Affect Cardiac Markers And

  • • Synthetic Organic Chemicals 5(F) • for Amendment

    • Synthetic Organic Chemicals 5(F) • for Amendment

  • Drug Consumption at Wholesale Prices in 2017 - 2020

    Drug Consumption at Wholesale Prices in 2017 - 2020

  • Application for Inclusion of Gadolinium-Based Contrast Agents to the WHO

    Application for Inclusion of Gadolinium-Based Contrast Agents to the WHO

  • Estonian Statistics on Medicines 2013 1/44

    Estonian Statistics on Medicines 2013 1/44

  • Environmentally Classified Pharmaceuticals 2014-2015

    Environmentally Classified Pharmaceuticals 2014-2015

  • Contrast Media

    Contrast Media

  • (PRAC) Der European Medicines Agency (EMA) Bezüglich Gadoliniumhaltiger MR- Kontrastmittel: Was Bedeutet Dies Für Die Radiologen in Der Schweiz?

    (PRAC) Der European Medicines Agency (EMA) Bezüglich Gadoliniumhaltiger MR- Kontrastmittel: Was Bedeutet Dies Für Die Radiologen in Der Schweiz?

  • FDA Listing of Established Pharmacologic Class Text Phrases January 2021

    FDA Listing of Established Pharmacologic Class Text Phrases January 2021

  • Stembook 2018.Pdf

    Stembook 2018.Pdf

Top View
  • Gadolinium Containing Contrast Agents
  • Gadoxetic Acid (Rinn) Preparations Acide Gadoxétique; Ácido Gadoxético; Acidum Gadoxeticum; Pharmacopoeias
  • 204781Orig1s000
  • Chitosan Modified with Gadolinium Diethylenetriaminepentaacetic Acid for Magnetic Resonance Imaging of DNA/Chitosan Nanoparticle
  • Pharmaceuticals Appendix
  • (12) Patent Application Publication (10) Pub. No.: US 2011/0269704 A1 Seigfried (43) Pub
  • (12) United States Patent (10) Patent No.: US 6,241,967 B1 Sachse Et Al
  • Original Article Gadopentetic Acid-Doped, Multifunctional
  • Biem Pharmaceuticals Is
  • RT291-2018 Contract Circular
  • Gadolinium Containing Contrast Agents (Gdcas) Are Complexes of Paramagnetic Gadolinium (III) with Different Types of Organic Chelators
  • )&F1y3x PHARMACEUTICAL APPENDIX to THE
  • Comprehensive Contrast Policy Page 2 of 25
  • Cancer Du Testicule
  • National Master List of Drugs and Lab Reagents
  • Pharmacologyonline 3: 728-781 (2010) Newsletter Bradu and Rossini
  • Biochemical Changes Associated with Intravenous Use of Contrast Media
  • Public Assessment Report for Paediatric Studies Submitted in Accordance with Article 45 of Regulation (EC) No1901/2006, As Amended


© 2024 Docslib.org    Feedback